TRCT
KRMD icon

Tower Research Capital (TRC)’s KORU Medical Systems KRMD Stock Holding History

Tower Research Capital (TRC)’s Portfolio KRMD Stock Details KRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15K Sell
3,570
-5,133
-59% -$21K ﹤0.01% 3785
2026
Q1 		$37.6K Buy
8,703
+6,741
+344% +$33.4K ﹤0.01% 2989
2025
Q4 		$11.4K Sell
1,962
-1,703
-46% -$8.15K ﹤0.01% 3604
2025
Q3 		$14K Buy
+3,665
New +$14K ﹤0.01% 3630
2025
Q2 		– Sell
-4,268
Closed -$10.8K – 5439
2025
Q1 		$10.8K Buy
4,268
+2,825
+196% +$10.5K ﹤0.01% 3605
2024
Q4 		$5.56K Sell
1,443
-85
-6% -$276 ﹤0.01% 4272
2024
Q3 		$4.17K Sell
1,528
-15,987
-91% -$39.4K ﹤0.01% 4649
2024
Q2 		$46.4K Buy
17,515
+12,021
+219% +$27.5K ﹤0.01% 3163
2024
Q1 		$13K Buy
5,494
+1,001
+22% +$2.15K ﹤0.01% 3428
2023
Q4 		$11K Sell
4,493
-1,025
-19% -$2.44K ﹤0.01% 4174
2023
Q3 		$14.9K Sell
5,518
-6,261
-53% -$17.1K ﹤0.01% 3651
2023
Q2 		$40.6K Buy
11,779
+10,476
+804% +$41.1K ﹤0.01% 2761
2023
Q1 		$6K Buy
1,303
+1,214
+1,364% +$4.78K ﹤0.01% 4850
2022
Q4 		$0 Buy
89
+5
+6% +$14 ﹤0.01% 6163
2022
Q3 		$0 Buy
+84
New +$208 ﹤0.01% 6299
2022
Q1 		– Sell
-4,087
Closed -$13K – 6346
2021
Q4 		$13K Buy
4,087
+429
+12% +$1.31K ﹤0.01% 4185
2021
Q3 		$10K Buy
3,658
+2,666
+269% +$8.82K ﹤0.01% 4321
2021
Q2 		$5K Sell
992
-6,778
-87% -$26.6K ﹤0.01% 4723
2021
Q1 		$27K Buy
7,770
+3,445
+80% +$14.9K ﹤0.01% 3642
2020
Q4 		$26K Sell
4,325
-20,281
-82% -$114K ﹤0.01% 3693
2020
Q3 		$178K Buy
24,606
+23,399
+1,939% +$208K ﹤0.01% 2676
2020
Q2 		$11K Buy
+1,207
New +$12.2K ﹤0.01% 3969
2020
Q1 		– Sell
-17,631
Closed -$115K – 3504
2019
Q4 		$115K Buy
+17,631
New +$86K 0.01% 856

Other funds holding KRMD

FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
TCM
Topline Capital Management Santa Monica, California $386M AUM 2.37% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SC
Simcoe Capital Spokane, Washington $164M AUM
MIM
Meros Investment Management Dallas, Texas $315M AUM 58.44% 1-Year Est. Return
LCM
Lionhunter Capital Management New York $222M AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $246M AUM 130.69% 1-Year Est. Return

Tower Research Capital (TRC)'s KRMD Position: Q2 2026 in Review

Tower Research Capital (TRC) reduced its KORU Medical Systems (KRMD) stake by 59% in Q2 2026, selling an estimated $21K and leaving 3,570 shares worth $15K. The position accounts for ﹤0.01% of the portfolio, ranked #3785.

Tower Research Capital (TRC) first reported a position in KRMD in Q4 2019 and has held it in 23 quarters since. The position peaked at $178K in Q3 2020. 84 funds tracked by Wall St. Rank hold KRMD as of Q2 2026.

  • Tower Research Capital (TRC) held 3,570 shares of KORU Medical Systems worth $15K as of Q2 2026.
  • Tower Research Capital (TRC) sold 5,133 KORU Medical Systems shares in Q2 2026, an estimated $21K.
  • KORU Medical Systems made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #3785 holding.
  • Tower Research Capital (TRC) first reported a position in KORU Medical Systems in Q4 2019 and has held it in 23 quarters since.
  • Tower Research Capital (TRC)'s KORU Medical Systems position peaked at $178K in Q3 2020.
  • 84 funds tracked by Wall St. Rank held KORU Medical Systems as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.